Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127065261 | 12706526 | 1 | I | 20160829 | 20160901 | 20160901 | PER | US-PFIZER INC-2016409636 | PFIZER | 0.00 | F | Y | 0.00000 | 20160901 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127065261 | 12706526 | 1 | PS | TOVIAZ | FESOTERODINE FUMARATE | 1 | Unknown | UNK, UNKNOWN FREQ. | U | 22030 | MODIFIED-RELEASE TABLET | ||||||||
| 127065261 | 12706526 | 2 | SS | MYRBETRIQ | MIRABEGRON | 1 | Unknown | 25 MG, UNKNOWN FREQ. | 0 | 25 | MG | TABLET | |||||||
| 127065261 | 12706526 | 3 | C | ESTROVEN | DIETARY SUPPLEMENT | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127065261 | 12706526 | 1 | Product used for unknown indication |
| 127065261 | 12706526 | 2 | Hypertonic bladder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127065261 | 12706526 | Condition aggravated | |
| 127065261 | 12706526 | Dry mouth | |
| 127065261 | 12706526 | Feeling abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127065261 | 12706526 | 2 | 2015 | 0 |